Rongsheng Jin

University of California-Irvine

NIH Rank #5397
  • R01 Holder
  • Translational
  • Early Career

NIH Funding · FY2024

Total Funding
$2M
Fiscal year 2024
Grants Awarded
4
Active NIH grants
National Rank
#5,397
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $2M across 4 grants · National rank #5397.

Top grants by award amount

Rongsheng Jin's NIH grant portfolio, ranked by award amount.

  • 5R01AI173059-02R01
    A versatile structure-based therapeutic platform for development of VHH-based antitoxin and antiviral agents
    $802.8K
    award amount
  • 5R01AI158503-04R01
    Developing broad-spectrum therapeutics against C. difficile toxins
    $752.8K
    award amount
  • 1R21AI180532-01A1R21
    Developing novel botulism antidotes and a platform for intra-neuronal delivery of nanobodies
    $263.9K
    award amount
  • 1R21AR084252-01R21
    Cell-penetrating botulinum proteases as topical therapeutics
    $172.7K
    award amount

Affiliations

Institutions that have administered grants for Rongsheng Jin.

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    University of California-Irvine
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Entered Top 50% Nationally
    Ranked #5397
  5. 2024
    Multi-Institutional Research
    Awards at 2 institutions